These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6692404)

  • 1. Preparation and interaction of a low-density lipoprotein:daunomycin complex with P388 leukemic cells.
    Iwanik MJ; Shaw KV; Ledwith BJ; Yanovich S; Shaw JM
    Cancer Res; 1984 Mar; 44(3):1206-15. PubMed ID: 6692404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of uptake and cytotoxicity of a low-density lipoprotein-daunomycin complex in P388 leukemic cells.
    Yanovich S; Preston L; Shaw JM
    Cancer Res; 1984 Aug; 44(8):3377-82. PubMed ID: 6744272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
    Yanovich S; Taub RN
    Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
    Yanovich S; Preston L
    Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring multidrug resistance using rhodamine 123.
    Kessel D
    Cancer Commun; 1989; 1(3):145-9. PubMed ID: 2639727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different distribution of daunomycin in plasma membranes from drug-sensitive and drug-resistant P388 leukemia cells.
    Ferrer-Montiel AV; Gonzalez-Ros JM; Ferragut JA
    Biochim Biophys Acta; 1992 Feb; 1104(1):111-6. PubMed ID: 1550837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of anthracycline-resistant strains of P388 leukemia].
    Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
    Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium, calmodulin, and protein content of adriamycin-resistant and -sensitive murine leukemic cells.
    Nair S; Samy TS; Krishan A
    Cancer Res; 1986 Jan; 46(1):229-32. PubMed ID: 3940193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phosphorus-containing metabolites in the cells of anthracycline-resistant strains of leukemia P388].
    Shiriaeva OA; Semenova NA; Sibel'dina LA; Goncharova SA; Konovalova NP
    Eksp Onkol; 1989; 11(4):70-3. PubMed ID: 2759015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
    Shiryaeva OA; Semenova NA; Sibeldina LA; Goncharova SA; Konovalova NP
    Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
    Shestova OL; Ogloblina TA; Litinskaia LL
    Eksp Onkol; 1990; 12(3):61-2. PubMed ID: 2344828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid kinetics of the interaction between daunomycin and drug-sensitive or drug-resistant P388 leukemia cells.
    Soto F; Canaves JM; Gonzalez-Ros JM; Ferragut JA
    FEBS Lett; 1992 Apr; 301(1):119-23. PubMed ID: 1451781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R; Grabowski D
    Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the pharmacokinetics of daunomycin in normal and leukemic rats.
    Nooter K; Sonneveld P; Martens A
    Cancer Res; 1985 Sep; 45(9):4020-5. PubMed ID: 4027999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
    Ramu A; Glaubiger D; Magrath IT; Joshi A
    Cancer Res; 1983 Nov; 43(11):5533-7. PubMed ID: 6311408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells: implications in drug-resistance phenomena.
    Escriba PV; Ferrer-Montiel AV; Ferragut JA; Gonzalez-Ros JM
    Biochemistry; 1990 Aug; 29(31):7275-82. PubMed ID: 2207106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High calcium content of pleiotropic drug-resistant P388 and K562 leukemia and Chinese hamster ovary cells.
    Tsuruo T; Iida H; Kawabata H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Nov; 44(11):5095-9. PubMed ID: 6593116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline photoaffinity labeling of a mitochondrial polypeptide in P388 murine leukemic cell lines.
    Averbuch SD; Glover CJ; Felsted RL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6120-4. PubMed ID: 3465435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayers.
    Kerr DJ; Hynds SA; Shepherd J; Packard CJ; Kaye SB
    Biochem Pharmacol; 1988 Oct; 37(20):3981-6. PubMed ID: 3190742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.